In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $34.09, marking a +2.13% move from the previous day ...

Despite a challenging year, the company has a lot to look forward to in the coming years.

What Viking Therapeutics stock’s recent moves tell you Viking Therapeutics (VKTX) shares closed at US$34.09, with the stock showing a 2.1% gain over the past day and a 6.9% rise over the past week, ...

Viking Therapeutics CEO Brian Lian said pharmaceutical companies are showing broader and deeper strategic interest in ...

We recently published 10 Big Names Delivering Outsized Gains. Viking Therapeutics Inc. (NASDAQ:VKTX) was one of the top ...

Viking Therapeutics remains a compelling obesity drugs contender, despite being in the pre-commercial phase. VKTX's dual-track pipeline (injectable and oral) and robust $700M liquidity position it ...

Viking has identified Neil Aubuchon as the person to oversee its commercial preparations. Aubuchon has joined the biotech as chief commercial officer, having previously held the same title at ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the stocks Jim Cramer discussed, along with recent market rotation. When a ...